MARATTO

article · Pharmacogenetics and Genomics

Prenatal efavirenz exposure is independently associated with maternal, but not fetal CYP2B6 genotype

20241 citationOpen accessUniversity of Ilorin

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The clinical relevance of the observed influence of maternal genetics on prenatal efavirenz exposure requires further investigation.

Research topics

  • Pregnancy and Medication Impact
  • HIV/AIDS Research and Interventions
  • Pharmacological Effects and Toxicity Studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1097/fpc.0000000000000542

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.